Jeffrey Gottfurcht The First Person in The World with Rheumatoid Arthritis to Successfully Summit Mount Everest Last year, Nutra Pharma sponsored Jeffrey Gottfurcht on his attempt to be the first person in the world with Rheumatoid Arthritis to climb Mount Everest. With rigorous training, mountain climbing expertise and Nyloxin™ in his backpack, Jeff realized his [...]

Read Full Post »

Paul Reid, PhD, is a leading world expert in the therapeutic use of snake venom neurotoxins. He is a co-founder and the CEO of ReceptoPharm, a Nutra Pharma drug discovery company. We talked to him about his recently published article “Cobra Venom: A Review of the Old Alternative to Opiate Analgesics” and other medicinal properties [...]

Read Full Post »

After years of practice and preparations, the day has finally come. Jeffrey Gottfurcht is officially the first person in the world with Rheumatoid Arthritis to reach the 29,035-foot summit of Mount Everest! Jeff scaled Mt. Everest with a 2-month supply of Nyloxin™ in his backpack For Jeff Gottfurcht, living with RA for more than a [...]

Read Full Post »

Jeff Gottfurcht is on the last leg of his uphill climb of Mount Everest! He recently left Camp 4 (26,300ft) and is heading to the summit (29,035ft)! It is night time in Nepal, so he is climbing in the dark with nothing but a headlamp and those of fellow climbers lighting the way. His family [...]

Read Full Post »

Statistics such as these give us insight into the significance of the chronic pain epidemic in America: http://www.publicdomainpictures.net It is estimated that approximately 1 out of 6 Americans, some 50 million people, experience the wrath of chronic pain (3 months or more of pain) during the course of a year. The American Academy of Pain [...]

Read Full Post »